Lung Cancer News

Never-smoker lung cancer survivors face a similar risk for second primary lung cancers as those who have ever smoked, according to study results published in JAMA Network Open.

Survival rates for patients with non-small cell lung cancer treated with first-line immunotherapy did not differ based on race or other socioeconomic determinants, according to a study in National Comprehensive Cancer Network.

For individuals with an incidentally detected lung nodule who are ineligible for lung cancer screening based on age, a lung nodule program may catch lung cancer early, according to results published in Journal of Thoracic Oncology.

Compared with army and air force veterans in the U.K. and Australia, naval veterans more frequently had lung cancers linked to asbestos exposure, according to results published in Scientific Reports.

Among four preventable risk factors for cancer mortality, smoking tobacco resulted in the most deaths and years of life lost in seven countries, according to data published in eClinicalMedicine.

Treatment with selpercatinib for advanced RET fusion-positive non-small cell lung cancer resulted in significantly longer PFS compared with platinum-based chemotherapy with or without pembrolizumab, study results showed.

A 960 mg daily dose of sotorasib conferred a longer OS benefit among certain patients with KRAS G12C-mutant advanced non-small cell lung cancer, results from a randomized phase 2 showed.

The FDA approved repotrectinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

Diagnosing early-stage lung cancer through low-dose CT screening significantly improves its cure rate, according to data published in Radiology.

The American Cancer Society has updated its lung cancer screening guideline to recommend yearly lung cancer screening for asymptomatic smokers or previous smokers aged 50 to 80 years with a 20-year or greater pack-year history.